AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CRISIL.NS

CRISIL Limited (CRISIL.NS) fair value

Financial Services · Financial Data & Stock Exchanges · NSE · India
₹4751.10-0.55%
Market cap ₹347.4BNext earnings 2025-07-14Updated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: there are no financial statements on file yet.
ACCE opinionCRISIL Limited (CRISIL.NS)
Fair value
Not available
ACCE price target
₹4520
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: ₹4751 at the close on 23 Oct 2026, 12:00 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
64
out of 100
P/E
39.3x
forward 31.6x
1-year return
-4.1%
Dividend yield
0.84%

CRISIL Limited in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

CRISIL Limited is an Indian credit rating agency that also runs a research and analytics business, selling ratings, risk scores, and data products to banks, insurers, and corporate issuers. Its moat rests on regulatory recognition: its ratings are embedded in Indian banking and bond-market rules, which gives it a franchise that is hard to replicate and a steady flow of recurring mandates. Revenue growth of 27.6% and a 29.1% return on equity show the business compounding well above its cost of capital, while a 24.7% operating margin reflects pricing power. The stock trades at 39.5 times trailing earnings and 31.7 times forward, so the multiple already prices in a lot of that growth, and the question for us is whether the analytics segment can keep lifting margins as ratings volumes cycle. At a 349.4 billion INR market cap with no index membership, it is a candidate for a deeper look on quality grounds, with valuation the main thing to test.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CRISIL.NS's valuation models land
Price
₹4751.10
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+4.5%
1 month
+3.2%
3 months
+9.3%
6 months
+11.3%
YTD
+9.8%
1 year
-4.1%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target₹4520first publication₹4777

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in INR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CRISIL.NS page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth80Value29Quality92Momentum56Total64
Valuation
Trailing P/E
39.3x
Forward P/E
31.6x
PEG
1.50
P/B
no data
EV / Revenue
no data
Book value/sh
no data
Enterprise value
no data
Profitability
ROE
29.1%
FCF yield
1.46%
ROIC
no data
Health and risk
Debt / equity
0.10
Dividend yield
0.84%
Beta
no data

Price

-4.3% · 1Y

Ask anything about CRISIL.NS

Answered from CRISIL Limited fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 17% of peers
low 12.1x39.3xhigh 65.0x
ROEbetter than 80% of peers
low 12%29%high 32%
Div yieldbetter than 17% of peers
low 0.3%0.8%high 5.7%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CRISIL.NS CRISIL Limited₹4751.10--39.3x29.1%9264
MCX.NS Multi Commodity Exchange of India Ltd.₹3020.30--65.0x-10076
MORN Morningstar Inc. Common Stock$224.89$16139% above20.5x32.0%8478
ASX.AX ASX LimitedA$66.06A$27149% above26.2x12.3%7660
X.TO TMX GroupC$57.43C$4045% above26.5x13.2%8678
FDS FactSet Research Systems Inc. Common Stock$331.32$22348% above22.7x25.5%8869
BOLSAA.MX Bolsa Mexicana de ValoresMXN 36.98MXN 3022% above12.1x22.5%8969

Sector report card

Where CRISIL.NS ranks against its sector peers on each metric.

Computing percentiles…